tm logo
Trademark Search
LEYTEVU

View On IC.GC.CA

LEYTEVU
FORMALIZED

on 13 Sep 2023

Last Applicant/ Owned by

AMGEN INC.

One Amgen Center DriveThousand Oaks CA 91320-1799

US

Serial Number

2281141 filed on 07th Aug 2023

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

LEYTEVU

Trademark usage description

pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory an Read More

Classification Information

Class [005]
Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure.

Classification kind code

12

Mark Details

Serial Number

2281141

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 67
on 27th Sep 2024		Agent Name Changed
Submitted for opposition 256
on 15th Jul 2024		Notification of Possible Opposition Sent
Submitted for opposition 48
on 26th Feb 2024		Agent Changed
Submitted for opposition 257
on 14th Sep 2023		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Sep 2023		Created
Submitted for opposition 31
on 13th Sep 2023		Formalized
Submitted for opposition 228
on 07th Aug 2023		International Registration
Submitted for opposition 30
on 07th Aug 2023		Filed